NeurAxis (NRXS) Stock Price, News & Analysis

Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Key Stats

• Today's Range: $2.40 to $2.70
• 50-Day Range: $2.58 to $3.24
• 52-Week Range: $1.80 to $5.20
• Volume: 17,331 shs
• Average Volume: 9,358 shs
• Market Capitalization: $17.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NRXS Stock Analysis - Frequently Asked Questions

How have NRXS shares performed this year?

NeurAxis' stock was trading at $2.67 on January 1st, 2024. Since then, NRXS stock has decreased by 3.6% and is now trading at $2.5750.
View the best growth stocks for 2024 here.

How were NeurAxis' earnings last quarter?

NeurAxis, Inc. (NASDAQ:NRXS) released its quarterly earnings results on Friday, August, 9th. The company reported ($0.42) earnings per share (EPS) for the quarter. The business had revenue of $0.61 million for the quarter.

When did NeurAxis IPO?

NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

How do I buy shares of NeurAxis?

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/09/2024
• Today: 9/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NRXS
• CUSIP: N/A
• CIK: 1933567
• Web: neuraxis.com
• Phone: (812) 689-0791
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.73)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-14,630,000.00
• Net Margins: -672.66%
• Pretax Margin: -672.71%
• Return on Equity: N/A
• Return on Assets: -787.15%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.28
• Quick Ratio: 0.27

Sales & Book Value

• Annual Sales: $2.27 million
• Price / Sales: 7.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.27) per share
• Price / Book: -9.54

Miscellaneous

• Outstanding Shares: 6,648,000
• Free Float: 5,638,000
• Market Cap: $17.12 million
• Optionable: Not Optionable
• Beta: N/A